Skip to main content
Premium Trial:

Request an Annual Quote

Biodesix Closes on $20M in Structured Debt Financing

Premium

Biodesix said this week that it has closed a structured debt financing with Capital Royalty Partners that provides the company with up to $20 million.

The funds will be used for ongoing development of Biodesix's technology platform and expansion of sales and marketing efforts in support of its VeriStrat proteomic test for guiding therapy in non-small cell lung cancer, the company said.

The deal follows the close by Biodesix in January of a $14.4 million Series E funding round.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.